Skip to main content
Shivalik Rasayan Ltd. logo

Shivalik Rasayan Ltd. — Investor Relations & Filings

Ticker · SHIVALIK ISIN · INE788J01021 LEI · 335800FEB4CFANKSV783 BSE.NS Manufacturing
Open in API
Filings indexed 220 across all filing types
Latest filing 2025-07-10 Regulatory Filings
Country IN India
Listing BSE.NS SHIVALIK

About Shivalik Rasayan Ltd.

https://shivalikrasayan.com/

Shivalik Rasayan Ltd. is a diversified chemical and pharmaceutical manufacturer specializing in the production of organophosphorus-based agrochemicals and high-potency active pharmaceutical ingredients (APIs). The company operates through two primary business segments: Agrochemicals and Pharmaceuticals. In the agrochemical sector, it is a leading producer of technical-grade insecticides, including Dimethoate and Malathion. Its pharmaceutical division focuses on the development and manufacture of oncology APIs and finished dosage forms, utilizing advanced research and development capabilities to serve global markets. Shivalik Rasayan maintains state-of-the-art manufacturing facilities designed to meet international regulatory standards, positioning itself as a key supplier of specialized chemical intermediates and complex therapeutic solutions for the healthcare and agricultural industries.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming details about securities dematerialized/rematerialized during the quarter ended June 30, 2025. It is a compliance certificate issued by the company and its registrar and share transfer agent. The document does not contain financial statements, management discussion, or detailed financial data. It is primarily a regulatory compliance certification related to securities and shareholding records. The document length is 3945 characters, which is relatively short and consistent with a certification or regulatory filing rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance certificate and not a financial report or announcement of a report.
2025-07-10 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal communication from Shivalik Rasayan Limited to stock exchanges (BSE and NSE) regarding the closure of the trading window for insiders and designated employees. It references the upcoming declaration of the company's unaudited financial results for the quarter ending June 2025 and mentions that the date of the board meeting will be intimated later. The document is short (2053 characters) and serves as an announcement about trading restrictions ahead of financial results, not the financial results themselves or a detailed report. It does not contain financial data or detailed analysis but is a regulatory compliance notice related to insider trading rules. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-06-30 English
Copy of Newspaper Publication
Regulatory Filings
2025-05-31 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is titled 'Statement for Deviation(s) or Variation(s) under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended 31.03.2025'. It discusses the utilization of funds raised through preferential issues and conversion of warrants into equity shares, confirming no deviation or variation in the use of funds. The document is a regulatory compliance statement related to fund utilization and does not contain financial statements or detailed financial analysis. It is a regulatory filing required by SEBI regulations to disclose deviations or variations in fund usage. The document length is 7555 characters, which is sufficient for a detailed regulatory filing but not a full financial report. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance disclosure rather than a financial report or capital update.
2025-05-31 English
Outcome of Board Meeting
Regulatory Filings
2025-05-30 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a disclosure under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which pertains to the yearly disclosure of shareholding by promoters and promoter groups. It is not a financial report, earnings release, or management discussion. The content focuses on shareholding information and compliance with takeover regulations. The document length is short (2532 characters) and it is a regulatory disclosure rather than a report or announcement of a report. Therefore, it fits best under Major Shareholding Notification (MRQ).
2025-05-29 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.